Rasbelon Injection
Marketer
Celon Laboratories Ltd
Salt Composition
Rasburicase (1.5mg)
Overview Rasbelon Injection
Allopurinol injection is administered to manage elevated uric acid levels arising from chemotherapy. This medication reduces serum uric acid, mitigating the risk of kidney complications in oncology patients. Administered intravenously at a slow rate by a healthcare professional, the dosage and frequency are determined by your physician based on individual needs and may vary. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits may not be immediately apparent, potentially taking weeks or months; discontinuation should only occur under medical supervision. Common side effects include nausea, headache, vomiting, and skin rash. However, serious reactions such as respiratory distress, chest pain, facial or throat swelling, intense itching, or vertigo necessitate immediate medical attention. Regular blood tests to monitor uric acid levels are typically conducted during treatment. Adequate hydration is recommended to prevent dehydration. Inform your doctor of all other medications and pre-existing health conditions to ensure safe and effective use, as drug interactions are possible.
Uses of Rasbelon Injection
Managing hyperuricemia secondary to cytotoxic therapy
Major Benefits of Rasbelon Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Rasbelon Injection:
- Nausea
- Headache
- Vomiting
- Rash
- Hives
- Fever
- Diarrhea
How to use Rasbelon Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Rasbelon Injection works:
Rasbelon Injection functions by interacting with an enzyme to convert uric acid into the inert compound allantoin, thus lowering serum uric acid concentrations.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Rasbelon Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Employing Rasbelon Injection during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Administration of Rasbelon Injection during lactation is likely safe. Available human data indicate minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
Rasbelon Injection's effect on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Rasbelon Injection appears safe for use in individuals with kidney impairment. Existing evidence indicates dose modification of Rasbelon Injection may be unnecessary for this population. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Rasbelon Injection appears safe for use in individuals with hepatic impairment. Existing evidence indicates dose modification may not be necessary. Physician consultation is advised.
What if you forget to take Rasbelon Injection :
NA
Facts to Know About Rasbelon Injection
| Label | Value |
|---|---|
| Chemical Type | Recombinant Xanthine Oxidoreductase |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Category | Chemotherapy with uricolytic agents |
3,018 People bought this recently